These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11841494)

  • 21. Familial Graves' disease associated with type 1 diabetes.
    Matoba K; Tojo K; Nemoto M; Tajima N
    Intern Med; 2009; 48(9):701-4. PubMed ID: 19420817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease.
    Ban Y; Ban Y; Taniyama M; Katagiri T
    Thyroid; 2000 Jun; 10(6):475-80. PubMed ID: 10907990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
    Ichimura M; Kaku H; Fukutani T; Koga H; Mukai T; Miyake I; Yamada K; Koda Y; Hiromatsu Y
    Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease associations and altered immune function in CD45 138G variant carriers.
    Boxall S; Stanton T; Hirai K; Ward V; Yasui T; Tahara H; Tamori A; Nishiguchi S; Shiomi S; Ishiko O; Inaba M; Nishizawa Y; Dawes R; Bodmer W; Beverley PC; Tchilian EZ
    Hum Mol Genet; 2004 Oct; 13(20):2377-84. PubMed ID: 15333587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population.
    Ballerini C; Rosati E; Salvetti M; Ristori G; Cannoni S; Biagioli T; Massacesi L; Sorbi S; Vergelli M
    Neurosci Lett; 2002 Aug; 328(3):325-7. PubMed ID: 12147336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans.
    Lopez ER; Zwermann O; Segni M; Meyer G; Reincke M; Seissler J; Herwig J; Usadel KH; Badenhoop K
    Eur J Endocrinol; 2004 Aug; 151(2):193-7. PubMed ID: 15296474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
    Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive human leukocyte antigen genotyping of patients with type 1 diabetes mellitus in Taiwan.
    Tung YC; Fann CS; Chang CC; Chu CC; Yang WS; Hwu WL; Chen PL; Tsai WY
    Pediatr Diabetes; 2018 Jun; 19(4):699-706. PubMed ID: 29383806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.
    Heward JM; Allahabadia A; Armitage M; Hattersley A; Dodson PM; Macleod K; Carr-Smith J; Daykin J; Daly A; Sheppard MC; Holder RL; Barnett AH; Franklyn JA; Gough SC
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2398-401. PubMed ID: 10404810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologically-related or incidental coexistence of diabetes mellitus and Graves' disease; discrimination by anti-GAD antibody measurement.
    Kusaka I; Nagasaka S; Fujibayashi K; Hayashi H; Kawakami A; Nakamura T; Rokkaku K; Saito T; Higashiyama M; Honda K; Ishikawa S; Saito T
    Endocr J; 1999 Dec; 46(6):747-54. PubMed ID: 10724349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
    Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
    Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves' disease.
    Philippou G; Krimitzas A; Kaltsas G; Anastasiou E; Souvatzoglou A; Alevizaki M
    J Endocrinol Invest; 2001 Feb; 24(2):88-91. PubMed ID: 11263477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children.
    Mochizuki M; Amemiya S; Kobayashi K; Kobayashi K; Shimura Y; Ishihara T; Nakagomi Y; Onigata K; Tamai S; Kasuga A; Nanazawa S
    Diabetes Care; 2003 Mar; 26(3):843-7. PubMed ID: 12610047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of vitamin D receptor gene polymorphism with susceptibility to Graves' disease in Eastern Croatian population: case-control study.
    Stefanić M; Karner I; Glavas-Obrovac L; Papić S; Vrdoljak D; Levak G; Krstonosić B
    Croat Med J; 2005 Aug; 46(4):639-46. PubMed ID: 16100768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease.
    Einarsdottir E; Söderström I; Löfgren-Burström A; Haraldsson S; Nilsson-Ardnor S; Penha-Goncalves C; Lind L; Holmgren G; Holmberg M; Asplund K; Holmberg D
    Eur J Hum Genet; 2003 Jan; 11(1):81-4. PubMed ID: 12529710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A heterozygous deletion of the autoimmune regulator (AIRE1) gene, autoimmune thyroid disease, and type 1 diabetes: no evidence for association.
    Nithiyananthan R; Heward JM; Allahabadia A; Barnett AH; Franklyn JA; Gough SC
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1320-2. PubMed ID: 10720083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polymorphism of the 52 triplet gene (nucleotide 253) of the TSH receptor in Basedow-Graves patients and in healthy controls].
    Kaczur V; Szalai C; Falus A; Nagy Z; Krajczár G; Balázs C
    Orv Hetil; 1997 Jun; 138(25):1625-8. PubMed ID: 9265143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans.
    Zilch CF; Walker AM; Timón M; Goff LK; Wallace DL; Beverley PC
    Eur J Immunol; 1998 Jan; 28(1):22-9. PubMed ID: 9485182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.